NewsDesk @bactiman63 GlaxoSmithKline (GSK) announced Monday it has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for PRIORIX (Measles, Mumps, and Rubella...

Earlier this week, Senate Minority Leader, Chuck Schumer of New York made a statement concerning the shortage of the popular shingles vaccine, Shingrix and seemed to link it to the current government...

GlaxoSmithKline (GSK) announced Friday it has received approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research expanding the indication for FLUARIX® QUADRIVALENT...

GSK and Medicines for Malaria Venture (MMV) today announced the submission of a new drug application (NDA) by GSK to the United States Food and Drug Administration (FDA), seeking approval of single-dose...

One week after Canadian officials approved GlaxoSmithKline’s shingles vaccine, Shingrix, the US Food and Drug Administration (FDA) gave the vaccine it’s approval. The FDA on Friday approved...

GlaxoSmithKline announced Friday that Shingrix has been approved in Canada for the prevention of shingles (herpes zoster) in people aged 50 years or older. Shingrix is a non-live, recombinant subunit...

GlaxoSmithKline announced Wednesday that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted unanimously that the data support...

GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) today announced positive results from two phase III studies of tafenoquine, an investigational 8-aminoquinoline, for the prevention of relapse...

GlaxoSmithKline (GSK) has voluntarily recalled 593,088 Ventolin HFA (albuterol sulfate) inhalers due to an issue with the delivery system. According to the US Food and Drug Administration (FDA), there...

GlaxoSmithKline  announced this week that it has submitted a Biologics License Application (BLA) for its candidate shingles vaccine, ShingrixTM, to the United States Food and Drug Administration (FDA),...